Skip to main content
Monday, November 16, 2026Nov 16

Senators investigate role of FDA with consulting firm that helped sell opioids and more business news

FILE - This Aug. 29, 2018, file photo shows an arrangement of Oxycodone pills in New York.  The three biggest U.S. drug distribution companies and the drugmaker Johnson & Johnson are on the verge of a $26 billion settlement covering thousands of lawsuits over the toll of opioids across the U.S., two people with knowledge of the plans told The Associated Press. The settlement involving AmerisourceBergen, Cardinal Health and McKesson is expected this week. A $1 billion-plus deal involving the three distributors and the state of New York was planned for Tuesday, July 20, 2021. (AP Photo/Mark Lennihan, File)
FILE - This Aug. 29, 2018, file photo shows an arrangement of Oxycodone pills in New York. The three biggest U.S. drug distribution companies and the drugmaker Johnson & Johnson are on the verge of a $26 billion settlement covering thousands of lawsuits over the toll of opioids across the U.S., two people with knowledge of the plans told The Associated Press. The settlement involving AmerisourceBergen, Cardinal Health and McKesson is expected this week. A $1 billion-plus deal involving the three distributors and the state of New York was planned for Tuesday, July 20, 2021. (AP Photo/Mark Lennihan, File)

Senators investigate FDA work with McKinsey

Several U.S. senators are questioning the Food and Drug Administration’s work with a consulting firm that helped businesses sell prescription painkillers during the nation’s overdose crisis.

Democrat Maggie Hassan of New Hampshire and Republican Chuck Grassley of Iowa, among others, have asked the FDA about potential conflicts of interest in its work with McKinsey and Co.

The senators sent a letter Monday to the FDA noting that the agency paid McKinsey more than $140 million after hiring it several times starting in 2008.

While helping the government, McKinsey “also worked for a wide range of actors in the opioid industry, including many of the companies that played a pivotal role in fueling the opioid epidemic that our country now faces,” the letter said.